ATE348111T1 - Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes - Google Patents

Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes

Info

Publication number
ATE348111T1
ATE348111T1 AT01978883T AT01978883T ATE348111T1 AT E348111 T1 ATE348111 T1 AT E348111T1 AT 01978883 T AT01978883 T AT 01978883T AT 01978883 T AT01978883 T AT 01978883T AT E348111 T1 ATE348111 T1 AT E348111T1
Authority
AT
Austria
Prior art keywords
human serum
warm
producing human
serum albumine
serum albumin
Prior art date
Application number
AT01978883T
Other languages
English (en)
Inventor
T Nouchi
H Mizokami
Kikuchi-Shi
Y Tajima
Y Miyatsu
M Sakaguchi
K Yagi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE348111T1 publication Critical patent/ATE348111T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT01978883T 2000-10-24 2001-10-24 Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes ATE348111T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000324030A JP4798833B2 (ja) 2000-10-24 2000-10-24 加熱処理工程を含むヒト血清アルブミンの製造方法

Publications (1)

Publication Number Publication Date
ATE348111T1 true ATE348111T1 (de) 2007-01-15

Family

ID=18801621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978883T ATE348111T1 (de) 2000-10-24 2001-10-24 Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes

Country Status (12)

Country Link
US (1) US6908749B2 (de)
EP (1) EP1329462B1 (de)
JP (1) JP4798833B2 (de)
KR (1) KR100839937B1 (de)
CN (1) CN1313493C (de)
AT (1) ATE348111T1 (de)
AU (1) AU783638B2 (de)
CA (1) CA2395590C (de)
DE (1) DE60125218T2 (de)
DK (1) DK1329462T3 (de)
ES (1) ES2272548T3 (de)
WO (1) WO2002034787A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1275981C (zh) * 2000-10-24 2006-09-20 财团法人化学及血清疗法研究所 人血清白蛋白多聚体的单体化方法
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
WO2004048588A1 (en) * 2002-11-26 2004-06-10 Novo Nordisk A/S Process for purifying a fermentation-derived product
GB0305989D0 (en) * 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
KR101308912B1 (ko) 2003-06-03 2013-09-23 노보 노르디스크 에이/에스 안정화된 약학적 펩티드 조성물
EP1633391B1 (de) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilisierte pharmazeutische peptid zusammensetzungen
KR101243648B1 (ko) 2003-11-20 2013-03-14 노보 노르디스크 에이/에스 제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
KR20070020204A (ko) * 2004-01-20 2007-02-20 쥬리디컬 파운데이션 더 케모-세로-쎄라퓨틱 리서치 인스티튜트 2가 양이온 존재 하에서 가열 처리에 의한 인간 혈청알부민의 제조 방법
JP4965446B2 (ja) 2004-08-31 2012-07-04 ノヴォ ノルディスク アー／エス ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス（ヒドロキシメチル）アミノメタンの使用
RU2413530C9 (ru) 2004-11-12 2021-05-18 Ново Нордиск А/С Стабильные препараты инсулинотропных пептидов
WO2007079886A1 (de) 2005-12-22 2007-07-19 Csl Behring Gmbh Oktanoatreduziertes human albumin
JP4936272B2 (ja) * 2006-02-13 2012-05-23 独立行政法人科学技術振興機構 バイオナノカプセルの効率的な精製法
US20080318864A1 (en) 2007-06-25 2008-12-25 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
EP3429345B1 (de) 2016-10-04 2019-09-11 Albumedix Ltd. Verwendungen von rekombinantem, von hefe abgeleitetem serumalbumin
CN106749623B (zh) * 2016-12-09 2020-04-10 浙江大学 一种基于混合模式的扩张床吸附分离人血白蛋白方法
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
EP4069200A1 (de) 2019-12-04 2022-10-12 Albumedix Ltd Verfahren und damit hergestellte zusammensetzungen
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
WO2026009167A1 (en) * 2024-07-02 2026-01-08 Csl Behring Ag A manufacturing process for albumin involving a heating step

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5071897A (de) * 1973-11-07 1975-06-14
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
JP2926722B2 (ja) 1988-10-20 1999-07-28 吉富製薬株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH04234326A (ja) * 1990-12-27 1992-08-24 Green Cross Corp:The アルブミン製剤及びその製法
JPH0671434A (ja) 1991-05-30 1994-03-15 Tadahiro Omi クリーンチャンバーの溶接方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3269504B2 (ja) * 1992-07-08 2002-03-25 三菱ウェルファーマ株式会社 ヒト血清アルブミンの製造方法
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
DE69739107D1 (de) * 1996-08-23 2008-12-24 Kirin Brewery Hefevektoren und verfahren für ihre benutzung für die produktion von proteinen.
JP2885212B2 (ja) * 1997-01-06 1999-04-19 吉富製薬株式会社 遺伝子操作由来のヒト血清アルブミンより得られる高純度ヒト血清アルブミン含有組成物

Also Published As

Publication number Publication date
DE60125218T2 (de) 2007-09-20
JP4798833B2 (ja) 2011-10-19
EP1329462A4 (de) 2004-09-08
WO2002034787A1 (fr) 2002-05-02
KR20020065609A (ko) 2002-08-13
EP1329462A1 (de) 2003-07-23
US20020182680A1 (en) 2002-12-05
DK1329462T3 (da) 2007-01-22
CA2395590A1 (en) 2002-05-02
CN1406246A (zh) 2003-03-26
CA2395590C (en) 2012-12-11
CN1313493C (zh) 2007-05-02
ES2272548T3 (es) 2007-05-01
AU783638B2 (en) 2005-11-17
US6908749B2 (en) 2005-06-21
AU1093602A (en) 2002-05-06
EP1329462B1 (de) 2006-12-13
JP2002128796A (ja) 2002-05-09
KR100839937B1 (ko) 2008-06-20
DE60125218D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
DE60125218D1 (de) Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes
DE60333201D1 (de) Verfahren zur herstellung von proteinen
ATE218036T1 (de) Verfahren zur herstellung eines proteinhydrolysates
DE60117008D1 (de) Giessform und verfahren zur herstellung von ophthalmischen linsen
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
DE60008411D1 (de) Verfahren zur herstellung von formteilen
DE59806195D1 (de) Verfahren zur herstellung von aliphatischen alkoholen
ATE326145T1 (de) Verfahren zur herstellung von frischkäse mit sojaproteinzusatz
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
DE10081270D2 (de) Verfahren zur prozessgesteuerten und kundenindividuellen Herstellung eines Gegenstandes
ATE316860T1 (de) Verfahren zur automatischen herstellung von brillenlinsen
ATE245192T1 (de) Verfahren zur herstellung von gereinigten papillomavirus proteinen
DE60112837T2 (de) Verfahren zur Herstellung von 1-Menthol
DE60027932D1 (de) Verfahren zur herstellung von proteinhydrolysaten
DE60010510D1 (de) Verfahren zur herstellung von mischungen von alkoholen/ketonen
DE60006489D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthio-buttersäure
ATE447547T1 (de) Verfahren zur herstellung von phenylessigsäure derivaten
ATE532793T1 (de) Verfahren zur herstellung von molekülen mit verminderter immunogenität
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
ATE350363T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäure amiden
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
DE50103231D1 (de) Verfahren zur herstellung von 7-(pyrazol-3-yl)benzoxazolen
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
DE69930488D1 (de) Verfahren zur Herstellung von Kontaktlinsen unter Umgebungsbedingungen
ATE427937T1 (de) Verfahren zur herstellung von 2,3- pyridindicarbonsauren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties